I. Franiak-Pietryga, “POTENTIAL GENETIC AGENT BFL1 FOR TARGETED THERAPY IN CHRONIC LYMPHOCYTIC LEUKEMIA”, ESJ, vol. 11, no. 27, Sep. 2015.